| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Nazartinib |
|---|
| Description | An inhibitor of mutant EGFRs; selective for EGFR mutant cell lines, including H3255 and HCC827 lung adenocarcinoma cells (IC50s = 6.11 and 1.52 nM, respectively) and resistant H1975 NSCLC cells (IC50 = 4.18 nM), over cells expressing wild-type EGFR (IC50 = 160.6 nM for HaCaT keratinocytes); decreases phosphorylation of EGFR in H3255, HCC827, and H1975 cells (EC50s = 5, 1, and 3 nM) and inhibits cell proliferation of H3255, HCC827, and H1975 cells (EC50s = 9, 11, and 25 nM) but does not affect cell proliferation in cell lines containing wild-type EGFR; reduces tumor growth in an HCC827 lung adenocarcinoma mouse xenograft model at doses ranging from 3 to 100 mg/kg per day |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | EGF816 NVS816 EGFR mutation mouse liver blood T790M L858R ex19del r EGF-816 NVS-816 H-3255 1975 HCC-827 |
|---|
| Gene, Accession, CAS # | CAS: 1508250-71-2 |
|---|
| Catalog # | 22409-10 |
|---|
| Price | |
|---|
| Order / More Info | Nazartinib from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|